CoChat

Liver X receptors at the intersection of lipid metabolism and atherogenesis

Open access
Lee, Stephen D., Tontonoz, Peter · 2015 · Atherosclerosis
Cited by 134

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Cholesterol homeostasis is maintained through the coordinated regulation of the trafficking, biosynthesis, absorption, and efflux of cholesterol. From the discovery that atherosclerotic plaques contain >20-fold more cholesterol than healthy aorta, to the identification of mutations in the LDL receptor as the cause of Familial Hypercholesterolemia, to the discovery of the statin drugs, cholesterol metabolism has been a focus of intensive investigation for decades1. Cholesterol is crucial for normal biological functions, including hormone synthesis, bile acid synthesis and maintaining cell membrane fluidity; however, excess circulating cholesterol is associated with CVD, especially when the cholesterol is carried by low-density lipoproteins (LDL). The evidence linking cholesterol to heart disease comes from population studies2-4, genetics, experimental models5, 6, and therapeutic intervention7. Despite tremendous gains in our understanding of CVD, it remains the leading cause of mortality worldwide8. In this review, we focus on molecular mechanisms by which Liver X Receptors (LXRs) mediate physiological responses to cellular and systemic cholesterol overload and the relationship of these pathways to atherogenesis (Figure 1). Figure 1 LXRs exert distinct effects on cholesterol and lipid metabolism in discrete cell types. Globally, LXR activation induces reverse cholesterol transport and reduces atherosclerotic plaque burden. Macrophage LXRs respond to oxidized sterol by increasing ... Transcriptional Regulation of Cholesterol Homeostasis Intracellular cholesterol homeostasis is maintained primarily through the actions of opposing transcription factors: LXRs, which are activated when cells accumulate excess cholesterol, and Sterol Response Element Binding Protein 2 (SREBP-2), which is active when cholesterol levels are low. The intricate details of how the SREBP-2 senses and responds to membrane cholesterol content have been elucidated, and readers are directed to a recent excellent review of this topic 9. LXRs are ligand-activated transcription factors belonging to the nuclear receptor superfamily. There are two highly homologous LXR proteins with distinct tissue expression patterns. LXRβ (NR1H2) is ubiquitously expressed, while LXRα (NR1H3) is highly expressed in liver, intestine, kidney, adipose and macrophages 10-12. Crystal structures of the two LXRs have revealed highly similar ligand binding domains 13-16. Although they appear to respond to the same endogenous sterol ligands 17, in vivo studies suggest that the two LXRs perform distinct physiological roles. This particularly true in the liver where the expression of LXRα dominates. LXRα is uniquely required for the efficient elimination of hepatic cholesterol in mice 18. LXRs form obligate heterodimers with Retinoid X Receptor (RXR) and modulate transcription of target genes via direct DNA binding. The optimal LXR response element is a direct repeat 4 (DR4) motif: repeats of the six base pair sequence AGTTCA separated by four base pairs 10, 12. Under basal conditions, corepressors bind the LXR/RXR heterodimer leading to transcriptional silencing. Ligand binding induces a conformational change in the heterodimer, releasing the corepressors and recruiting coactivators 19, 20. LXRs are activated physiologically by oxidized derivatives of cholesterol, oxysterols, which are synthesized when the cell accumulates excess cholesterol 21-23. Many LXR target genes have been identified in experiments screening for the gene expression consequences of cellular cholesterol loading or synthetic LXR agonist treatment 24.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2015.06.042

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 134

Metadata

Authors
Lee, S. D., & Tontonoz, P.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2015-09
Volume
242
Issue
1
Pages
29-36
ISSN
0021-9150 (ISSN-L)
OpenAlex
W1574430758
Cited by
134
References
38
FWCI
11.51
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.